Home > Result Summaries: Compounds > GSK227855A Result Summaries: GSK227855A GSKStudy ID Phase Title Summary (Download) 102396_1 phase 1/2 Study to evaluate reactogenicity and immunogenicity of GSK Bio’s experimental influenza vaccine in an elderly population aged over 65 years and previously vaccinated in 2003 with the experimental influenza vaccine in the Explo-Flu-001 clinical trial (0 citation(s)) 227855/001_1 phase 1 Phase I study in elderly population aged over 65 years in order to evaluate reactogenicity and immunogenicity of GSK Bio experimental Influenza vaccine or a Whole virus vaccine. The commercial inactivated split vaccine Fluarix will be used as reference. (0 citation(s))
